» Articles » PMID: 10680925

Consequences to Hearing During the Conservative Management of Vestibular Schwannomas

Overview
Journal Laryngoscope
Date 2000 Feb 19
PMID 10680925
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the risk of loss of serviceable hearing during the conservative management of vestibular schwannomas.

Study Design: Retrospective case review.

Methods: Twenty-five patients with a radiological diagnosis of unilateral vestibular schwannoma were managed conservatively for a mean duration of 43.8 months (range, 12-194 mo). The pure-tone average (PTA) (0.5, 1, 2, and 3 kHz) and speech discrimination scores (SDS) were measured at regular intervals throughout the entire duration of follow-up. Serviceable hearing was defined using two criteria: 70% SDS/30 dB PTA (the 70/30 rule) and 50% SDS/50 dB PTA (the 50/50 rule). The size and growth rate of tumors were determined according to the American Academy of Otolaryngology-Head and Neck Surgery guidelines (1995). Intervention was recommended if there was evidence of continuous or rapid radiological tumor growth, and/or increasing symptoms or signs suggestive of tumor growth.

Results: The risk of loss of serviceable hearing for the total group was 43% using the 70/30 rule and 42% using the 50/50 rule. Tumor growth was considered significant (> 1 mm) in 8 tumors (32%) and nonsignificant in 17 (68%). The risk of loss of serviceable hearing for the tumor-growth group was 67% using the 70/30 rule and 80% using the 50/50 rule. In contrast, the risk of loss of serviceable hearing for the no tumor-growth group was 25% using the 70/30 rule and 14% using the 50/50 rule. No audiological factors predictive of tumor growth were identified.

Conclusions: There is a significant risk of loss of serviceable hearing during the conservative management of vestibular schwannomas. This risk appears to be greater in tumors that demonstrate significant growth.

Citing Articles

Analysis of the association between vestibular schwannoma and hearing status using a newly developed radiomics technique.

Lim K, Lee S, Song I, Yoon H, Kim H, Lee Y Eur Arch Otorhinolaryngol. 2024; 281(6):2951-2957.

PMID: 38183454 DOI: 10.1007/s00405-023-08410-1.


A Case of Vestibular Schwannoma with Deafness Showing Remarkable Hearing Recovery Following Hearing-Preserving Surgery.

Sakaki Y, Hosoya M, Nishiyama T, Wakabayashi T, Shimanuki M, Ozawa H J Int Adv Otol. 2023; 19(5):426-430.

PMID: 37789631 PMC: 10645190. DOI: 10.5152/iao.2023.221035.


Hearing improvement after vestibular schwannoma surgery in the era of the hearing preservation rule - case report and literature review.

Fik Z, Lazak J, Hruba S, cada Z, Zverrna E, Betka J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021; 166(3):347-352.

PMID: 34897296 DOI: 10.5507/bp.2021.067.


Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review.

Gan J, Zhang Y, Wu J, Lei D, Zhang F, Zhao H Front Oncol. 2021; 11:687201.

PMID: 34476211 PMC: 8406761. DOI: 10.3389/fonc.2021.687201.


Endolymphatic Hydrops in Fluctuating Hearing Loss and Recurrent Vertigo.

Dominguez P, Manrique-Huarte R, Suarez-Vega V, Lopez-Laguna N, Guajardo C, Perez-Fernandez N Front Surg. 2021; 8:673847.

PMID: 34136529 PMC: 8202684. DOI: 10.3389/fsurg.2021.673847.